Nabriva Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
(WorldNews Europe)

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Chief Executive Officer Ted Schroeder will provide a company overview and business update at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 at 1:50 p.m. ET. The conference is being held at the InterContinental New York Barclay Hotel in New York, NY. The presentation will be webcast live and may be accessed by visiting the `Investors` section of the Company`s website under the `Events and...